Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers.

Author: ArnoldSusan E, BhattDeepak L, JenningsLisa K, LeeJohn S, MaysMichael C, PollackCharles V, UmsteadBret R, WeitzJeffrey I, XuSherry

Paper Details 
Original Abstract of the Article :
Label="BACKGROUND">Ticagrelor is an oral P2Y<sub>12</sub> inhibitor that is used with aspirin to reduce the risk of ischemic events among patients with acute coronary syndromes or previous myocardial infarction. Spontaneous major bleeding and bleeding associated with urgent invasive procedures are c...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1056/NEJMoa1901778

データ提供:米国国立医学図書館(NLM)

Antibody-Based Ticagrelor Reversal Agent in Healthy Volunteers.

This study explores the potential of [研究手法] for reversing the effects of a drug called ticagrelor, which is used to prevent blood clots. The authors conducted a study with healthy volunteers to [主な目的] by evaluating the safety and efficacy of a new antibody-based reversal agent. They found that [主要な発見] highlighting its potential as a safe and effective treatment option for managing bleeding complications associated with ticagrelor. This research is like a journey across the desert of antiplatelet medication, seeking a reliable solution for unexpected bleeding events.

A New Tool for Managing Bleeding Complications: Antibody-Based Ticagrelor Reversal

This research suggests that [研究結果] which could significantly improve patient safety. It’s like discovering a hidden oasis in the desert of antiplatelet medication. The researchers’ findings provide hope for patients who experience bleeding complications while taking ticagrelor, offering a potential way to quickly reverse its effects and prevent further complications.

Living with Antiplatelet Medications: What You Should Know

This study reminds us that [健康的なベネフィットもしくはリスク] and that seeking professional help is essential for managing these medications. It’s like navigating a desert with a compass – you need to be aware of potential risks and know how to handle unexpected situations. If you are taking antiplatelet medications, talk to your doctor about any concerns you may have and ensure you are using them safely and effectively.

Dr.Camel's Conclusion

This research demonstrates the incredible potential of antibody-based therapies for addressing specific medical challenges. By harnessing the power of the immune system, scientists are developing innovative solutions for a wide range of conditions. Like a camel traversing a vast and unforgiving desert, we must embrace new technologies and approaches to find solutions for the challenges we face in the world of healthcare.

Date :
  1. Date Completed 2019-05-21
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

30883047

DOI: Digital Object Identifier

10.1056/NEJMoa1901778

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.